Escherichia coli is a common conditional pathogen, for which antibiotic therapy is considered an effective treatment. The imprudent use of antibiotics has led to the increase of multiple-antibiotic-resistant E. coli species. With the incidence of antibiotic resistance reaching a crisis point, it is imperative to find alternative treatments for multidrug-resistant infections. Using phage for pathogen control is a promising treatment option to combat bacterial resistance. In this study, a novel virulent Podoviridae phage Kayfunavirus TM1 infecting Escherichia coli was isolated from pig farm sewage in Guangxi, China. The one-step growth curve with the optimal multiplicity of infection of 0.01 revealed a latent period of 10 min and a burst size of 50 plaque-forming units per cell. The stability test reveals that it is stable from 4 to 60 °C and pH from 3 to 11. The double-stranded DNA genome of phage Kayfunavirus TM1 is composed of 39,948 base pairs with a GC content of 50.03%.
Keyphrases
- escherichia coli
- pseudomonas aeruginosa
- multidrug resistant
- single cell
- public health
- biofilm formation
- klebsiella pneumoniae
- genome wide
- stem cells
- cell therapy
- drug resistant
- candida albicans
- microbial community
- risk factors
- single molecule
- combination therapy
- dna methylation
- mass spectrometry
- staphylococcus aureus
- high frequency
- replacement therapy
- wastewater treatment
- smoking cessation
- binding protein